An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants
…, J Chemouny, L Golbin, B Schvartz, P Malvezzi… - Kidney international, 2020 - Elsevier
Notwithstanding the ongoing coronavirus disease-2019 (Covid-19) pandemic, information
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty. …
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty. …
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation …
…, F Pattou, PY Benhamou, P Malvezzi… - The lancet Diabetes & …, 2018 - thelancet.com
Background Islet transplantation is indicated for patients with type 1 diabetes with severe
hypoglycaemia or after kidney transplantation. We did a randomised trial to assess the efficacy …
hypoglycaemia or after kidney transplantation. We did a randomised trial to assess the efficacy …
Recurrence of FSGS after kidney transplantation in adults
…, M Bugnazet, T Jouve, P Malvezzi… - Clinical Journal of the …, 2020 - journals.lww.com
Results Among 11,742 kidney transplant recipients screened for FSGS, 176 had a diagnosis
of idiopathic FSGS and were included. FSGS recurred in 57 patients (32%; 95% confidence …
of idiopathic FSGS and were included. FSGS recurred in 57 patients (32%; 95% confidence …
IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)
…, R Snanoudj, C Colosio, B Schvartz, P Malvezzi… - Kidney international, 2020 - Elsevier
End stage kidney disease increase the risk of COVID-19 related death but how the kidney
replacement strategy should be adapted during the pandemic is unknown. Chronic …
replacement strategy should be adapted during the pandemic is unknown. Chronic …
Recurrence of IgA nephropathy after kidney transplantation in adults
…, T Jouve, M Bugnazet, P Malvezzi… - Clinical Journal of the …, 2021 - journals.lww.com
Results Out of 504 transplant recipients with IgA nephropathy, recurrent IgA deposits were
identified by kidney biopsy in 82 patients; cumulative incidence of recurrence was 23% at 15 …
identified by kidney biopsy in 82 patients; cumulative incidence of recurrence was 23% at 15 …
Influence of intention to adhere, beliefs and satisfaction about medicines on adherence in solid organ transplant recipients
…, E Borrel, MN Hilleret, P Malvezzi… - …, 2014 - journals.lww.com
Methods Adherence was assessed with a self-reported medication adherence scale and IS
blood trough concentrations over 6 months, in four transplant units. Satisfaction and beliefs …
blood trough concentrations over 6 months, in four transplant units. Satisfaction and beliefs …
The safety of calcineurin inhibitors for kidney-transplant patients
P Malvezzi, L Rostaing - Expert opinion on drug safety, 2015 - Taylor & Francis
Introduction: Cyclosporine-A and tacrolimus are the cornerstones in modern immunosuppression
after organ transplantation. They are potent inhibitors of calcineurin, that is, so-called …
after organ transplantation. They are potent inhibitors of calcineurin, that is, so-called …
Adverse effects of immunosuppression after liver transplantation
J Noble, F Terrec, P Malvezzi, L Rostaing - Best Practice & Research …, 2021 - Elsevier
After solid organ transplantation the cornerstone of immunosuppression is based on
calcineurin inhibitors (CNIs), mostly tacrolimus. However, CNIs have a very narrow therapeutic …
calcineurin inhibitors (CNIs), mostly tacrolimus. However, CNIs have a very narrow therapeutic …
A multicentre, patient-and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided …
…, M Banas, B Banas, K Budde, O Viklicky, P Malvezzi… - Trials, 2023 - Springer
Background Immunosuppression after kidney transplantation is mainly guided via plasma
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor‐specific antibodies
LE Croze, R Tetaz, M Roustit, P Malvezzi… - Transplant …, 2014 - Wiley Online Library
In kidney transplantation, conversion to mammalian target of rapamycin ( mTOR ) inhibitors
may avoid calcineurin inhibitor ( CNI ) nephrotoxicity, but its impact on post‐transplant allo‐…
may avoid calcineurin inhibitor ( CNI ) nephrotoxicity, but its impact on post‐transplant allo‐…
